Guggenheim Initiates Coverage on Tempus AI (NASDAQ:TEM)

Equities researchers at Guggenheim started coverage on shares of Tempus AI (NASDAQ:TEM) in a research note issued on Monday,Benzinga reports. The brokerage set a “buy” rating and a $74.00 price target on the stock. Guggenheim’s price objective indicates a potential upside of 46.71% from the company’s current price.

Other analysts have also issued reports about the company. Bank of America lowered Tempus AI from a “buy” rating to a “neutral” rating and lifted their target price for the stock from $45.00 to $60.00 in a research report on Wednesday, October 2nd. Piper Sandler reissued a “neutral” rating and set a $70.00 price target (up previously from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Loop Capital upped their price target on shares of Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a report on Tuesday, October 15th. Finally, Stifel Nicolaus lowered shares of Tempus AI from a “buy” rating to a “hold” rating and raised their price objective for the stock from $45.00 to $65.00 in a report on Monday, November 11th. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat, Tempus AI presently has an average rating of “Moderate Buy” and a consensus target price of $56.20.

Tempus AI Trading Down 5.1 %

TEM opened at $50.44 on Monday. The firm’s 50 day moving average price is $53.54. Tempus AI has a 52-week low of $22.89 and a 52-week high of $79.49. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.

Hedge Funds Weigh In On Tempus AI

Institutional investors have recently made changes to their positions in the stock. First Horizon Advisors Inc. bought a new position in Tempus AI during the 3rd quarter worth $30,000. Sandia Investment Management LP bought a new position in shares of Tempus AI during the second quarter worth about $136,000. Vestor Capital LLC acquired a new stake in shares of Tempus AI in the 3rd quarter worth about $153,000. Stifel Financial Corp acquired a new stake in shares of Tempus AI in the 3rd quarter worth about $218,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd bought a new stake in Tempus AI in the 3rd quarter valued at about $258,000. 24.22% of the stock is owned by institutional investors.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.